Ahima, R. S. und Flier, J. S. (2000): Adipose tissue as an endocrine organ, Trends Endocrinol Metab 11 [8], Seite 327-332. Albiston, A. L.; McDowall, S. G.; Matsacos, D.; Sim, P.; Clune, E.; Mustafa, T.; Lee, J.; Mendelsohn, F. A.; Simpson, R. J.; Connolly, L. M. und Chai, S. Y. (2001): Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase, J Biol Chem. 276 [52], Seite 48623-48626. Allison, D. B.; Fontaine, K. R.; Manson, J. E.; Stevens, J. und VanItallie, T. B. (1999): Annual deaths attributable to obesity in the United States, JAMA 282 [16], Seite 1530-1538. Alzheimer, Alois (1906): Über eine eigenartige Erkrankung der Hirnrinde, Zentralblatt für Nervenheilkunde und Psychiatrie 30, Seite 177-179. Arnal, J. F.; Castano, C.; Maupas, E.; Mugniot, A.; Darblade, B.; Gourdy, P.; Michel, J. B. und Bayard, F. (2001b): Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice, Atherosclerosis 155 [2], Seite 291-295. Atwood, C. S.; Moir, R. D.; Huang, X.; Scarpa, R. C.; Bacarra, N. M.; Romano, D. M.; Hartshorn, M. A.; Tanzi, R. E. und Bush, A. I. (1998): Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J Biol Chem. 273 [21], Seite 12817-12826. Aust, L; Dongowski, G; Frenz, U; Täufel, A und Noack, R (2001): Estimation of available energy of dietary fibres by indirect calorimetry in rats, Eur.J Nutr. 40, Seite 23-29. Backstrom, J. R.; Lim, G. P.; Cullen, M. J. und Tokes, Z. A. (1996): Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40), J Neurosci. 16 [24], Seite 7910-7919. Bado, A.; Roze, C.; Lewin, M. J. und Dubrasquet, M. (1989): Endogenous opioid peptides in the control of food intake in cats, Peptides 10 [5], Seite 967-971. Bae, S. J.; Matsunaga, Y.; Takenaka, M.; Tanaka, Y.; Hamazaki, Y.; Shimizu, K. und Katayama, I. (2002): Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts, Int.Arch.Allergy Immunol. 127 [4], Seite 316-321. Barker, P. E.; Shipp, M. A.; D'Adamio, L.; Masteller, E. L. und Reinherz, E. L. (1989): The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27), J Immunol. 142 [1], Seite 283-287. Barnes, K.; Matsas, R.; Hooper, N. M.; Turner, A. J. und Kenny, A. J. (1988): Endopeptidase-24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and peptidyl dipeptidase A ('angiotensin converting enzyme'), is a marker for a set of striatal efferent fibres, Neuroscience 27 [3], Seite 799-817. Barnes, K.; Turner, A. J. und Kenny, A. J. (1993): An immunoelectron microscopic study of pig substantia nigra shows co-localization of endopeptidase-24.11 with substance P, Neuroscience 53 [4], Seite 1073-1082. Barsh, G. S.; Farooqi, I. S. und O'Rahilly, S. (2000a): Genetics of body-weight regulation, Nature 404 [6778], Seite 644-651. Beliaev, N. A.; Brusov, O. S. und Panchenko, L. F. (1983b): [Effect of chronic alcohol consumption on activity of enkephalinase A in rat striatum, hypothalamus and midbrain], Vopr.Med.Khim. 29 [1], Seite 102-107. URL: PM:6340337 Bergmann, KE und Mensink, GB (1999): Körpermaße und Übergewicht, Gesundheitswesen 61, Seite S115-S120. Berman, Yemiliya; Mzhavia, Nino; Polonskaia, Ann und Devi, Lakshmi A. (2001): Impaired Prohormone Convertases in Cpefat/Cpefat Mice, Journal of Biological Chemistry 276 [2], Seite 1466-1473. Beyreuther, Konrad (1999): Alzheimersche Krankheit - Molekulares Verständnis und therapeutische Implikationen, http://www.fes.de/fulltext/asfo/00234toc.htm. Bitan, G.; Kirkitadze, M. D.; Lomakin, A.; Vollers, S. S.; Benedek, G. B. und Teplow, D. B. (2003): Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways, Proc.Natl.Acad.Sci.U.S.A 100 [1], Seite 330-335. Bitan, Gal; Kirkitadze, Marina D.; Lomakin, Aleksey; Vollers, Sabrina S.; Benedek, George B. und Teplow, David B. (2003): Amyloid beta -protein (Abeta ) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways, Proceedings of the National Academy of Sciences 100 [1], Seite 330-335. Blum, K.; Trachtenberg, M. C.; Elliott, C. E.; Dingler, M. L.; Sexton, R. L.; Samuels, A. I. und Cataldie, L. (1988): Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE, Alcohol 5 [6], Seite 481-493. Bradford, M. M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal.Biochem 72, Seite 248-254. Brady, K. T. und Sonne, S. C. (1999): The role of stress in alcohol use, alcoholism treatment, and relapse, Alcohol Res.Health 23 [4], Seite 263-271. Brzyska, M.; Bacia, A. und Elbaum, D. (2001): Oxidative and hydrolytic properties of beta-amyloid, Eur.J Biochem 268 [12], Seite 3443-3454. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C. M. und Stefani, M. (2002): Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature 416 [6880], Seite 507-511. Buenger, L.; Herrendoerfer, G. und Renne, U. (1990): Results of long term-selection for growth traits in laboratory mice., Proceedings of the 4th World Congress on Genetics Applied to Livestock Production 13, Seite 321-324. Bundesministerium für Gesundheit und Soziale Sicherung (2000): Alkoholkonsum und alkoholbezogene Störungen in Deutschland, Schriftenreihe des BMG [128]. Bundesregierung (1996): Situation der Demenzkranken in der Bundesrepublik Deutschland, Deutscher Bundestag Drucksache 13/5257 13/5257. Bush, A. I.; Pettingell, W. H.; Multhaup, G.; Paradis, M.; Vonsattel, J. P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L. und Tanzi, R. E. (1994): Rapid induction of Alzheimer A beta amyloid formation by zinc, Science 265 [5177], Seite 1464-1467. Carpentier, M.; Robitaille, Y.; DesGroseillers, L.; Boileau, G. und Marcinkiewicz, M. (2002): Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy, J Neuropathol.Exp Neurol. 61 [10], Seite 849-856. Carson, J. A. und Turner, A. J. (2002): Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?, J Neurochem 81 [1], Seite 1-8. Chen, H.; Charlat, O.; Tartaglia, L. A.; Woolf, E. A.; Weng, X.; Ellis, S. J.; Lakey, N. D.; Culpepper, J.; Moore, K. J.; Breitbart, R. E.; Duyk, G. M.; Tepper, R. I. und Morgenstern, J. P. (1996): Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice, Cell 84 [3], Seite 491-495. Clarimon, J.; Munoz, F. J.; Boada, M.; Tarraga, L.; Sunyer, J.; Bertranpetit, J. und Comas, D. (2003): Possible increased risk for Alzheimer's disease associated with neprilysin gene, J Neural Transm. 110 [6], Seite 651-657. Connelly, J. C.; Skidgel, R. A.; Schulz, W. W.; Johnson, A. R. und Erdos, E. G. (1985): Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide, Proc.Natl.Acad.Sci.U.S.A 82 [24], Seite 8737-8741. Cowen, Michael S.; Chen, Feng und Lawrence, Andrew J. (2004): Neuropeptides: implications for alcoholism, Journal of Neurochemistry 89 [2], Seite 273-285. Crabbe, J. C. (2002): Genetic contributions to addiction, Annu.Rev.Psychol. 53, Seite 435-462. Crabbe, John C.; Wahlsten, Douglas und Dudek, Bruce C. (1999): Genetics of Mouse Behavior: Interactions with Laboratory Environment, Science 284 [5420], Seite 1670-1672. Curtain, C. C.; Ali, F.; Volitakis, I.; Cherny, R. A.; Norton, R. S.; Beyreuther, K.; Barrow, C. J.; Masters, C. L.; Bush, A. I. und Barnham, K. J. (2001): Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J Biol Chem. 276 [23], Seite 20466-20473. D'Adamio, L.; Shipp, M. A.; Masteller, E. L. und Reinherz, E. L. (1989): Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions, Proc.Natl.Acad.Sci.U.S.A 86 [18], Seite 7103-7107. d'Uscio, L. V.; Quaschning, T.; Burnett, J. C., Jr. und Luscher, T. F. (2001): Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition, Hypertension 37 [1], Seite 28-33. DeMattos, R. B.; Bales, K. R.; Cummins, D. J.; Paul, S. M. und Holtzman, D. M. (2002): Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease, Science 295 [5563], Seite 2264-2267. Devault, A.; Lazure, C.; Nault, C.; Le Moual, H.; Seidah, N. G.; Chretien, M.; Kahn, P.; Powell, J.; Mallet, J.; Beaumont, A.; Roques, B. P.; Crine, P. und Boileau, G. (1987a): Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA, EMBO J 6 [5], Seite 1317-1322. Dion, N.; Cohen, P.; Crine, P. und Boileau, G. (1997): Characterisation of neprilysin (EC 3.4.24.11) S2' subsite, FEBS Lett. 411 [1], Seite 140-144. Duhl, D. M.; Vrieling, H.; Miller, K. A.; Wolff, G. L. und Barsh, G. S. (1994): Neomorphic agouti mutations in obese yellow mice, Nat Genet. 8 [1], Seite 59-65. During, M. J.; Cao, L.; Zuzga, D. S.; Francis, J. S.; Fitzsimons, H. L.; Jiao, X.; Bland, R. J.; Klugmann, M.; Banks, W. A.; Drucker, D. J. und Haile, C. N. (2003a): Glucagon-like peptide-1 receptor is involved in learning and neuroprotection, Nat Med 9 [9], Seite 1173-1179. Eckman, E. A.; Reed, D. K. und Eckman, C. B. (2001): Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme, J Biol Chem. 276 [27], Seite 24540-24548. Engeli, S.; Schling, P.; Gorzelniak, K.; Boschmann, M.; Janke, J.; Ailhaud, G.; Teboul, M.; Massiera, F. und Sharma, A. M. (2003b): The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?, Int.J Biochem Cell Biol 35 [6], Seite 807-825. Enoch, MA (2003): Pharmacogenomics of alcohol response and addiction, Am J Pharmacogenomics 3 [4], Seite 217-232. Esteban, J. A. (2004): Living with the enemy: a physiological role for the beta-amyloid peptide, Trends Neurosci. 27 [1], Seite 1-3. Farooqi, I. S.; Matarese, G.; Lord, G. M.; Keogh, J. M.; Lawrence, E.; Agwu, C.; Sanna, V.; Jebb, S. A.; Perna, F.; Fontana, S.; Lechler, R. I.; DePaoli, A. M. und O'Rahilly, S. (2002): Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency, J Clin Invest 110 [8], Seite 1093-1103. Fezoui, Y.; Hartley, D. M.; Harper, J. D.; Khurana, R.; Walsh, D. M.; Condron, M. M.; Selkoe, D. J.; Lansbury, P. T.; Fink, A. L. und Teplow, D. B. (2000b): An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments, Amyloid 7 [3], Seite 166-178. Findlay, G. S.; Wick, M. J.; Mascia, M. P.; Wallace, D.; Miller, G. W.; Harris, R. A. und Blednov, Y. A. (2002): Transgenic expression of a mutant glycine receptor decreases alcohol sensitivity of mice, J Pharmacol.Exp Ther. 300 [2], Seite 526-534. Francis, R.; McGrath, G.; Zhang, J.; Ruddy, D. A.; Sym, M.; Apfeld, J.; Nicoll, M.; Maxwell, M.; Hai, B.; Ellis, M. C.; Parks, A. L.; Xu, W.; Li, J.; Gurney, M.; Myers, R. L.; Himes, C. S.; Hiebsch, R.; Ruble, C.; Nye, J. S. und Curtis, D. (2002): aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev Cell 3 [1], Seite 85-97. Fraser, P. E.; Nguyen, J. T.; Inouye, H.; Surewicz, W. K.; Selkoe, D. J.; Podlisny, M. B. und Kirschner, D. A. (1992): Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein, Biochemistry 31 [44], Seite 10716-10723. Frette, Catherine; Pezet, Sophie; El Nabout, Rita Azzi; Bertrand, Jean-Pierre; Pham, Quang Thieu; Kauffmann, Francine und Lafuma, Chantal (1998b): Relationship of serum neutral endopeptidase E.C.3.4.24.11 activity to alcohol consumption, Alcohol Clin Exp Res 22 [7], Seite 1405-1408. Fricker, L. D.; Berman, Y. L.; Leiter, E. H. und Devi, L. A. (1996): Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing, J Biol Chem. 271 [48], Seite 30619-30624. Friedland, J. und Silverstein, E. (1976): A sensitive fluorimetric assay for serum angiotensin-converting enzyme, Am J Clin Pathol 66 [2], Seite 416-424. Fulcher, I. S. und Kenny, A. J. (1983): Proteins of the kidney microvillar membrane. The amphipathic forms of endopeptidase purified from pig kidneys, Biochem J 211 [3], Seite 743-753. GeneCards (2004): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=summary&list_uids=4311. George, S. R.; Roldan, L.; Lui, A. und Naranjo, C. A. (1991): Endogenous opioids are involved in the genetically determined high preference for ethanol consumption, Alcohol Clin Exp Res 15 [4], Seite 668-672. Gianoulakis, C. (2004): Endogenous opioids and addiction to alcohol and other drugs of abuse, Curr.Top.Med.Chem. 4 [1], Seite 39-50. URL: PM:14754375 Glenner, G. G. und Wong, C. W. (1984): Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys.Res Commun. 120 [3], Seite 885-890. Gordon, H. W. (2002): Early environmental stress and biological vulnerability to drug abuse, Psychoneuroendocrinology 27 [1-2], Seite 115-126. Grupp, L. A. (1992): Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats, Pharmacol.Biochem Behav. 41 [1], Seite 105-108. Grupp, L. A. und Chow, S. Y. (1992): Time-dependent effect of the angiotensin converting enzyme inhibitor, abutapril, on voluntary alcohol intake in the rat, Alcohol Alcohol 27 [3], Seite 267-271. Gulpinar, M. A. und Yegen, B. C. (2004): The physiology of learning and memory: role of peptides and stress, Curr.Protein Pept.Sci. 5 [6], Seite 457-473. Haemmerle, G.; Zimmermann, R.; Hayn, M.; Theussl, C.; Waeg, G.; Wagner, E.; Sattler, W.; Magin, T. M.; Wagner, E. F. und Zechner, R. (2002b): Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis, J Biol Chem. 277 [7], Seite 4806-4815. Hama, E.; Shirotani, K.; Masumoto, H.; Sekine-Aizawa, Y.; Aizawa, H. und Saido, T. C. (2001): Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons, Journal of Biochemistry 130 [6], Seite 721-726. Hardy, J. und Selkoe, D. J. (2002): The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 [5580], Seite 353-356. Heimann, A. S.; Favarato, M. H.; Gozzo, F. C.; Rioli, V.; Carreno, F. R.; Eberlin, M. N.; Ferro, E. S.; Krege, J. H. und Krieger, J. E. (2004): ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight, Physiol Genomics. Helin, K.; Tikkanen, I.; Hohenthal, U. und Fyhrquist, F. (1994): Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes, Eur.J Pharmacol. 264 [2], Seite 135-141. Herpertz, S (2003): Psychotherapie der Adipositas, Dtsch Arztebl 100 [20], Seite A1367-A1373. Hilbich, C.; Kisters-Woike, B.; Reed, J.; Masters, C. L. und Beyreuther, K. (1991): Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4, Eur.J Biochem 201 [1], Seite 61-69. Hill, J. O.; Wyatt, H. R.; Reed, G. W. und Peters, J. C. (2003): Obesity and the environment: where do we go from here?, Science 299 [5608], Seite 853-855. Hirsch, J.; Leibel, R. L. und Chua, S. C. (1992): A clinical perspective on peptides and food intake, Am J Clin Nutr. 55 [1 Suppl], Seite 296S-298S. URL: PM:1728843 Howell, S.; Nalbantoglu, J. und Crine, P. (1995): Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism, Peptides 16 [4], Seite 647-652. Hu, J.; Igarashi, A.; Kamata, M. und Nakagawa, H. (2001): Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity, J Biol Chem. 276 [51], Seite 47863-47868. Huang, X.; Cuajungco, M. P.; Atwood, C. S.; Hartshorn, M. A.; Tyndall, J. D.; Hanson, G. R.; Stokes, K. C.; Leopold, M.; Multhaup, G.; Goldstein, L. E.; Scarpa, R. C.; Saunders, A. J.; Lim, J.; Moir, R. D.; Glabe, C.; Bowden, E. F.; Masters, C. L.; Fairlie, D. P.; Tanzi, R. E. und Bush, A. I. (1999): Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem. 274 [52], Seite 37111-37116. Hulme, E. C. (1992): Receptor preparations for binding studies, Hulme, E. C., Receptor--Ligand Interactions, a Practical Approach , IRL Press. Hupe-Sodmann, K.; Goke, R.; Goke, B.; Thole, H. H.; Zimmermann, B.; Voigt, K. und McGregor, G. P. (1997): Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells, Peptides 18 [5], Seite 625-632. Hwang, B. H.; Stewart, R.; Zhang, J. K.; Lumeng, L. und Li, T. K. (2004): Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference, Brain Res 1026 [1], Seite 143-150. Iwata, N.; Takaki, Y.; Fukami, S.; Tsubuki, S. und Saido, T. C. (2002): Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging, J Neurosci.Res 70 [3], Seite 493-500. Iwata, N.; Tsubuki, S.; Takaki, Y.; Shirotani, K.; Lu, B.; Gerard, N. P.; Gerard, C.; Hama, E.; Lee, H. J. und Saido, T. C. (2001d): Metabolic regulation of brain Abeta by neprilysin, Science 292 [5521], Seite 1550-1552. Iwata, N.; Tsubuki, S.; Takaki, Y.; Watanabe, K.; Sekiguchi, M.; Hosoki, E.; Kawashima-Morishima, M.; Lee, H. J.; Hama, E.; Sekine-Aizawa, Y. und Saido, T. C. (2000b): Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat Med. 6 [2], Seite 143-150. Iwata, Nobuhisa; Higuchi, Makoto und Saido, Takaomi C. (2005a): Metabolism of amyloid beta peptide and Alzheimer's disease, Pharmacol.Thera. 108 [2], Seite 129-148. Iwata, Nobuhisa; Mizukami, Hiroaki; Shirotani, Keiro; Takaki, Yoshie; Muramatsu, Shin ichi; Lu, Bao; Gerard, Norma P.; Gerard, Craig; Ozawa, Keiya und Saido, Takaomi C. (2004): Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-{beta} Peptide in Mouse Brain, Journal of Neuroscience 24 [4], Seite 991-998. Jacobowitz, David M.; Kresse, Adelheid und Skofitsch, Gerhard (2004): Galanin in the brain: chemoarchitectonics and brain cartography--a historical review*1, Peptides 25 [3], Seite 433-464. Janek, K.; Rothemund, S.; Gast, K.; Beyermann, M.; Zipper, J.; Fabian, H.; Bienert, M. und Krause, E. (2001): Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues, Biochemistry 40 [18], Seite 5457-5463. Jansen, S. (2004): Welt-Alzheimertag, Pharm.Ztg. 149 [38], Seite 46-46. Johnstone, E. M.; Chaney, M. O.; Norris, F. H.; Pascual, R. und Little, S. P. (1991a): Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis, Brain Res Mol.Brain Res 10 [4], Seite 299-305. Kenny, A. J. (1977): Proteinases associated with cell membranes, Barrett, A. J., Proteinases in Mammalian Cells and Tissues , Seite 393-444, Elsevier,